The new ADA recommendation to prevent the epidemic of diabetes
To prevent the epidemic of diabetes, combined treatment recommendation is necessary. Recently, American Diabetes Association (ADA) and European Association of Study of Diabetes (EASD), the two leading association of this sector, for the first time, have given a combined protocol to treat and to control diabetes, says a press release.According to WHO, 120 million diabetic patients reside in Asia. The same report suggests that there will be nearly 180 million diabetic patients in the region by 2025. According to this new treatment protocol, named "2006 Consensus", physicians can reduce the blood sugar level of type-2 diabetes patients by most effective way. In addition to lifestyle intervention and oral drug Metformin, they strongly advocate the use of basal insulin as first line insulin. This algorithm represents, for the first time, the world's leading diabetes societies' published joint guidelines for the treatment of diabetes. As a part of regular roll out programme, leading organisation, American Diabetes Association, and Sanofi-Aventis jointly organised a scientific conference and workshop session in the Asia Pacific Region with this new recommended treatment protocol. In This remarkable educational initiative, taken by the ADA Faculty, named, "Standing Together Against Diabetes", held in Thailand, about more than 500 leading physicians from this region attended the programme and created a great milestone by sharing their research information. ADA's recommendations for basal insulin are based on conclusive studies that show effective, long-term results in diabetic patients. The full ADA Clinical Practice Recommendations are available on the ADA website www.diabetes.org > For Health Professionals and Scientists > Clinical Practice Recommendations.
|
|
